University of Nebraska Medical Center

DigitalCommons@UNMC
Journal Articles: Epidemiology

Epidemiology

2018

Temporal and Geospatial Trends of Pediatric Cancer Incidence in
Nebraska Over a 24-Year Period
Evi A. Farazi
Shinobu Watanabe-Galloway
L. Westman
B. Rettig
P. Hunt

See next page for additional authors

Follow this and additional works at: https://digitalcommons.unmc.edu/coph_epidem_articles
Part of the Epidemiology Commons

Authors
Evi A. Farazi, Shinobu Watanabe-Galloway, L. Westman, B. Rettig, P. Hunt, R. Cammack, John W. Sparks,
and Don W. Coulter

&DQFHU(SLGHPLRORJ\  ²

Contents lists available at ScienceDirect

Cancer Epidemiology
journal homepage: www.elsevier.com/locate/canep

Temporal and geospatial trends of pediatric cancer incidence in Nebraska
over a 24-year period
P.A. Farazia, , S. Watanabe-Gallowaya, L. Westmana, B. Rettigb, P. Huntc, R. Cammackc,
J.W. Sparksd, D.W. Coulterd
⁎

a

College of Public Health, University of Nebraska Medical Center, Omaha, NE, United States
Department of Health and Human Services, Lincoln, NE, United States
c
Department of Geography and Geology, University of Nebraska-Omaha, Omaha, NE, United States
d
Department of Pediatrics, University of Nebraska Medical Center, Omaha, NE, United States
b

A R T I C L E I N F O

A B S T R A C T

Keywords:
Pediatric cancer
Epidemiology
Rural

Background: Data from the Surveillance, Epidemiology, and End Results (SEER) revealed that the incidence of
pediatric cancer in Nebraska exceeded the national average during 2009–2013. Further investigation could help
understand these patterns.
Methods: This retrospective cohort study investigated pediatric cancer (0–19 years old) age adjusted incidence
rates (AAR) in Nebraska using the Nebraska Cancer Registry. SEER AARs were also calculated as a proxy for
pediatric cancer incidence in the United States (1990–2013) and compared to the Nebraska data. Geographic
Information System (GIS) mapping was also used to display the spatial distribution of cancer in Nebraska at the
county level. Finally, location–allocation analysis (LAA) was performed to identify a site for the placement of a
medical center to best accommodate rural pediatric cancer cases.
Results: The AAR of pediatric cancers was 173.3 per 1,000,000 in Nebraska compared to 167.1 per 1,000,000 in
SEER. The AAR for lymphoma was signiﬁcantly higher in Nebraska (28.1 vs. 24.6 per 1,000,000; p = 0.009). For
the 15–19 age group, the AAR for the 3 most common pediatric cancers were higher in Nebraska (p < 0.05).
Twenty-three counties located > 2 h driving distance to care facilities showed at least a 10% higher incidence
than the overall state AAR. GIS mapping identiﬁed a second potential treatment site that would alleviate this
geographic burden.
Conclusions: Regional diﬀerences within Nebraska present a challenge for rural populations. Novel use of GIS
mapping to highlight regional diﬀerences and identify solutions for access to care issues could be used by similar
states.

1. Introduction
Cancer is the leading cause of death from disease among children in
the United States [1]. In 2017, it is expected that there will be 10,270
new cases of pediatric tumors in children 0–14 years old [1]. Pediatric
cancer represents a spectrum of diseases. A report of pediatric cancer
incidence from 62 countries revealed an AAR of 140.6 per million
person-years in children 0–14 years old (2001–2010). Leukemia was
the most common cancer, followed by CNS tumors and lymphomas [2].
A study in the United States showed that acute lymphoblastic leukemia
(ALL) increased during 2001–2008 and was most prevalent in Hispanic
populations and Western regions of the US [3]. Furthermore, disparities
in pediatric cancer mortality have been suggested in a Tennessee study,

which showed that African American children tended to reside in
proximity to death clusters in rural areas [4].
The etiologies of pediatric cancers are poorly understood; genetic
and environmental factors play key roles [5]. Pediatric cancer patient
care remains an imposing challenge to patients and their families since
treatment often requires multiple therapeutic techniques (e.g., surgery,
chemotherapy, radiation therapy, stem cell transplantation [6]) administered by a team of specialists located in an urban area [7,8].
Consequently, a major public health issue arises for states with a large
rural population living a great distance from urban specialized children’s cancer care centers [8,9]. The problem is further magniﬁed by
the fact that three-quarters of pediatric cancer survivors will require
long-term subspecialty management [10]. Therefore, from the time of
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diagnosis to the survivorship and surveillance phase, patients and their
families will make multiple trips to medical professionals. Previous
research has shown that rural patients experience greater disruptions in
school, work and other obligations than their urban counterparts for
cancer care [9,11–17].
One of the rural states facing these issues in pediatric cancer care is
Nebraska, which is the 15th largest state covering 77,355 square miles
[18,19]. Data from the National Cancer Institute ’s SEER Program and
the National Program of Cancer Registries reveal that the average incidence of pediatric cancer in Nebraska exceeds the national average for
2009 to 2013 (19.3 versus 17.4 per 100,000) [20–22]. Over one third of
Nebraska residents live in a rural area, but pediatric cancer care for the
entire population is provided only in the urban area of Omaha in the
eastern part of the state. Consequently, many patients and their families
need to travel a long distance to seek care. Furthermore, concerns about
the potential eﬀects of environmental factors (e.g., pesticide, agricultural run-oﬀs) on pediatric cancer rates have been debated [23].
Nebraska is one of the leading agriculture states, ranking 4th in total
agriculture receipts [24]. In 2016, 48,400 farms were in operation in
Nebraska with over 45,000,000 acres utilized by operating farms [24].
Considering the challenges in pediatric cancer care due to the rural
nature of the state, and recent data from SEER indicating an increased
incidence of pediatric cancer in Nebraska in recent reporting periods,
we sought to evaluate the incidence of pediatric cancer in Nebraska by
comparing the state registry data to a nationally representative sample
from the Surveillance, Epidemiology, and End Results (SEER). We hypothesized that pediatric cancer incidence within the State may vary by
location given the existence of some urban areas amidst the large distinctive rural areas of the State. Given that pediatric cancer is a rare
event, we evaluated 24 years of registry data to ensure the validity of
our statistics. Geographic Information System (GIS) mapping was employed to display the spatial distribution of children with cancer in the
state. Finally, we used our data to develop a strategy to improve the
access to care for rural populations in Nebraska and identiﬁed a potential secondary site for a pediatric cancer care center.

Hispanic black, and other. Age was grouped into four categories: 0–4,
5–9, 10–14, and 15–19 years. Fisher exact test was used for comparing
proportions between groups (NE versus SEER). All incidence rates (IRs)
were calculated per million people and age-adjusted to the 2000 US
standard population. IRs were displayed with 95% conﬁdence intervals
(CI) and compared with relative risk (RR) between Nebraska (primary
group) and SEER (comparison group). All Nebraska IRs were calculated
with SAS 9.4 [29] by using bridge-race population estimates prepared
by the U.S. census Bureau and the National Center for Health Statistics
[30]. SEER IRs were calculated with SEER*Stat, version, 8.3.2[31]. Due
to restriction of race and ethnicity in SEER 9, age-adjusted IRs (AARs)
by race and ethnicity groups were retrieved by using SEER 13 [26],
which restricted the year of interest to 1992–2013. For the trend analysis, annual percentage change (APC) was calculated by ﬁtting a regression line to data where the dependent variable was the natural
logarithm of the data and calendar year was the independent variable.
SEER*Stat was used to generate APCs and corresponding CIs for Nebraska data and SEER data. Trends of Nebraska pediatric cancer incidence were shown against national pediatric cancer incidence trends
represented by SEER.
Location–Allocation analysis (LAA) of ArcGIS version 10.5 [32] was
employed to determine a secondary site that would decrease the burden
of travel from rural communities. To obtain possible facility locations,
we started with existing pediatric cancer centers and added potential
new facility locations based on existing adult cancer centers in the study
area. With network/impedance, facility locations, and demands (locations of existing or potential cancer patients), the LAA can select the
best candidate location to reduce travel time for patients and their family in the study area. Such selection was based on the calculations of
LAA using alternative demands: ﬁrst with the pediatric cancer patient’s
addresses and second with the existing child population at county
centroids. This study was approved by the University of Nebraska
Medical Center Institutional Review Board (543-15 EP).

2. Methods

3.1. Demographics and tumor patterns of pediatric cancer patients

2.1. Study design and data sources
This was a retrospective cohort study using the Nebraska Cancer
Registry (NCR) and SEER 9 Registries as data sources. The NCR received gold certiﬁcation from the North American Cancer Registry for
95% case ascertainment, ensuring the reliability of the analysis results
[25]. SEER 9 registries research data (2015 November submission [20])
cover areas including San Francisco, Connecticut, Detroit, Hawaii,
Iowa, New Mexico, Seattle, Utah, and Atlanta [26].

Of the 2094 pediatric cancer patients identiﬁed in Nebraska during
1990–2013, similar to the pattern in the US (SEER data), more pediatric
cancers were observed in the youngest (0–4 years) and oldest (15–19
years) age groups (Table 1). A higher proportion of leukemias were
observed at the oldest age (15–19) group in Nebraska (21%) compared
to the US (15.4%) (p = 0.001). This age trend was also true for all
pediatric cancers, lymphoma and CNS tumors. The race distribution of
pediatric cancers was diﬀerent between Nebraska and US SEER, underlining a predominance of non-Hispanic white patients in Nebraska.

2.2. Case deﬁnition

3.2. Incidence rates of pediatric cancers in Nebraska versus US SEER

Cases were restricted to children and adolescent patients (0–19
years) diagnosed with a primary malignant neoplasm between year
1990 and 2013. Diagnoses were grouped into 12 main groups by histology and primary site according to SEER Site/Histology Recode based
on the International Classiﬁcation of Childhood Cancer Third Edition
(ICCC-3) and the International Classiﬁcation of Diseases for Oncology,
Third Edition (ICD-O-3) [27]. We included in situ and malignant cases
for urinary bladder cancer (ICD-O-67.9) to be consistent with other
SEER reports [28]. To analyze the brain and CNS cancers, we also
evaluated benign and uncertain cases for 2004- 2013.

In general, the incidence of all and individual pediatric cancers was
slightly higher in Nebraska compared to the US SEER population,
however, the relative risk was within the 95% conﬁdence intervals
(Table 2). AAR of all pediatric cancers was 173.3 per million in Nebraska compared to 167.1 per million in the US SEER population. The
AAR for lymphoma was signiﬁcantly higher in Nebraska (28.1 per
million vs. 24.6 per million; p = 0.009). Interestingly, for the oldest
(15–19) age group, the age-speciﬁc rates for all and three most common
pediatric cancers were higher in Nebraska compared to US SEER
(Table 2). The IR for leukemias in 15–19 year-old patients was 33.7 per
million in Nebraska compared to 25.9 per million in US SEER
(RR = 1.3, 95% CI = 1.1–1.6). Similarly, the IRs for lymphomas and
CNS tumors were higher in Nebraska compared to US SEER (RR = 1.2,
95% CI = 1.0–1.4 for lymphoma and RR = 1.3, 95% CI = 1.0–1.6).
The AARs of overall pediatric cancers diﬀered by sex, with males
showing higher incidence than females in both populations (Table 2).

3. Results

2.3. Measures and data analysis
The following variables were examined in the analyses: age group,
gender, and race/ethnicity. Due to the small size of certain races/ethnicities, race/ethnicity was re-coded as non-Hispanic white, non
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(Table 3). During 1990–2003, only malignant cases were required to be
recorded, and therefore the SEER database may have an under-representation of the benign cases that were not reported. For this reason,
our analyses did not address benign and uncertain cases for this period.
Interestingly, the AARs of malignant CNS tumors were the same in
Nebraska and US SEER over this period. During 2004–2013, however, a
higher incidence was observed for both malignant and benign brain
tumors in Nebraska compared to US SEER (Nebraska AAR: 38.1/
1,000,000 vs SEER AAR: 30.5/1,000,000 and Nebraska AAR: 22.7/
1,000,000 vs SEER AAR: 17.2/1,000,000). This was consistent with the
higher APC observed for the entire period.

Table 1
Demographic characteristics of pediatric cancer patients in Nebraska and SEER database
(1990–2013).
Nebraska
All Pediatric
Cancers
(N = 2094)

Leukemia
(n = 496)

Lymphoma
(n = 339)

CNS (n = 401)

Age
0–4
5–9
10–14
15–19

No.
645
362
371
716

%
30.8
17.3
17.7
34.2

No.
226
99
67
104

%
45.5
20.0
13.5
21.0*

No.
32
52
71
184

%
9.4
15.3
20.9
54.4

No.
126
108
84
83

%
31.4
26.9
21.0
20.7

Gender
Male
Female

1155
939

55.2
44.8

273
223

55.0
45.0

215
124

63.4
36.6

230
171

57.4
42.6

Race
NH-White
OTHER
Unknown

1569
296
60

81.5
15.4
3.1

344
97
4

77.3
21.8
0.9

275
34
4

87.9
10.9
1.2

316
49
11

84.0
13.0
3.0

3.3. Geographic distribution of pediatric cancers in Nebraska
We mapped the incidence of pediatric cancers in Nebraska at the
county level to determine if there are clusters of higher pediatric cancer
incidence. The distribution of all pediatric cancers and brain cancer is
shown in Fig. 2. Delineating the distribution of pediatric cancer cases
across the state is important in addressing access to care issues. Nebraska is a rural state with Children’s Hospital and Medical Center and
Nebraska Medicine being the two main pediatric care centers located in
urban Omaha. Geographic distribution of the incidence rates of all
pediatric cancers varies across Nebraska, with 26 counties showing at
least 10% higher incidence compared to the overall state incidence rate
and 24 of these counties located in rural areas at a large distance (more
than 1-h driving distance) from urban health care centers.

SEER
All Pediatric
Cancers
(N = 30136)

Leukemia
(n = 7459)

Lymphoma
(n = 4373)

CNS (n = 5447)

Age
0–4
5–9
10–14
15–19

No.
9655
5107
5816
9558

%
32.1
16.9
19.3
31.7

No.
3438
1663
1208
1150

%
46.1
22.3
16.2
15.4*

No.
342
629
1139
2263

%
7.8
14.4
26.1
51.7

No.
1816
1474
1235
922

%
33.3
27.1
22.7
16.9

Gender
Male
Female

16182
13954

53.7
46.3

4160
3299

55.8
44.2

2576
1797

58.9
41.1

3006
2441

55.2
44.8

Race
NH-White
OTHER
Unknown

21484
18944
528

52.5
46.3
1.2

5059
5860
93

45.9
53.2
0.9

3200
2499
71

55.5
43.3
1.2

4014
2917
93

57.1
41.5
1.4

4. Discussion and conclusions
These data represent the longest evaluation of the cumulative incidence of pediatric cancer within a state. In accordance with data from
SEER, our study revealed higher APCs for pediatric cancers in Nebraska
compared to US SEER for the last ﬁve years of our evaluation period
(2008–2013). However, the incidence of pediatric cancer in Nebraska is
similar to that reported in the US SEER database over 1990–2013. This
ﬁnding warrants further investigation to determine the causes for the
increased incidence of pediatric cancer in Nebraska in the most recent
years. Furthermore, IR calculations at a ﬁner geospatial resolution
within the state reveals interesting intrastate regional diﬀerences in
pediatric cancer incidence. Most of the areas with higher incidence are
rural areas at a greater distance from the specialized cancer treatment
centers in urban Omaha, raising access to care issues for these patients.
Finally, age-speciﬁc IR analyses reveal higher incidence of pediatric
cancers in adolescents in Nebraska compared to US SEER, which needs
to be investigated further both at the etiological and psychosocial level.
Our geospatial analyses suggest regional diﬀerences in pediatric
cancer incidence. Speciﬁcally, an area stretching from Holt and Knox
counties in the north through Red Willow, Furnas, Harlon, and Franklin
counties in the south exhibits a higher IR than the rest of the state.
These counties are an average of 227 miles from the treatment centers
in the urban area of Omaha, with 4–7 h of travel time for these patients
to obtain care. Given the rural nature of these counties and the eﬀect of
access to care for patients in these locations, this increased incidence
can have a profound impact. Previous research investigating the geographic burden of care in pediatric cancer reveals that a two-hour or
greater driving distance from the treatment center can have ﬁnancial
and social impacts for patients and their families [9]. Rural patients
have greater out-of-pocket travel expenses, report signiﬁcantly greater
ﬁnancial burden, miss more school days, and are at an increased risk of
having to repeat a grade [9],11–17,33–35]. A closer examination of the
patients and families living in these rural locations in Nebraska to
evaluate diﬀerences in survival, quality of life, and overall cost of care
would provide more deﬁnitive information on how pediatric cancer
care delivery in Nebraska could be improved.
Another interesting observation is that the APC over the entire
period evaluated is higher for Nebraska than US SEER; especially for

* P = 0.001 Nebraska vs US SEER Leukema for 15–19 year olds.

Males in Nebraska showed overall a higher incidence of pediatric
cancer compared to US SEER data. This sex diﬀerence was more pronounced in lymphoma and CNS tumors (p < 0.05). The AAR for
lymphomas in males was 34.7 per million in Nebraska compared to
28.2 per million in US SEER (RR = 1.3, 95% CI = 1.1–1.4). The same
trend was shown for CNS tumors with AARs of 37.4 per million in
Nebraska compared to 32.5 per million in US SEER (RR = 1.2, 95%
CI = 1.0–1.3, p < 0.05). The AARs of all and individual pediatric
cancers were very similar between females in Nebraska and US SEER.
The AARs of all pediatric cancers, leukemia, lymphoma and CNS were
not statistically diﬀerent between non-Hispanic whites (NHW) in Nebraska and US SEER.
We next investigated the trends of these pediatric cancers over time
in both Nebraska and US SEER (Fig. 1). While the AAR trends were
similar between Nebraska and US SEER between years 1990 and 2007,
diﬀerences were observed during 2008–2013 when the AARs for lymphomas, and CNS tumors were higher in Nebraska compared to US
SEER. The most consistent diﬀerence over time for years 2008–2013
was observed for CNS tumors. The APCs for all pediatric cancers, as
well as leukemias, lymphomas, and CNS were higher for Nebraska
compared to US SEER (2008–2013). This diﬀerence was particularly
pronounced for lymphomas (APC were 1.9% for Nebraska and 0.5% for
SEER) and CNS tumors (APCs were 1.7% for Nebraska and 0.2% for
SEER).
For CNS tumors, both US SEER and Nebraska started accurately
reporting on benign cases after 2004. Therefore, we investigated the
incidence of CNS tumors for two periods (1990–2003 and 2004–2013)




174.5a
(165.9–183.2)
139.3a
(123.4–155.3)

186.8a
(176.0–197.6)
159.2a
(149.0–169.4)

220.0
(203.0–236.9)
121.6
(109.1–134.1)
122.2
(109.8–134.6)
232.3
(215.3–249.3)

182.3a
(179.9–184.8)
148.2a
(146.1–150.3)

175.2a
(172.5–177.9)
158.6a
(156.0–161.2)

214.0
(209.7–218.3)
113.8
(110.7–116.9)
128.3
(125.1–131.7)
215.1
(210.8–219.4)

1.0
(0.9–1.0)
0.9
(0.8–1.1)

1.1
(1.0–1.1)*
1.0
(0.9–1.1)

1.0
(0.9–1.1)
1.1
(1.0–1.2)
1.0
(0.9–1.1)
1.1
(1.0–1.2)*

1.0
(0.9–1.1)

38.9a
(34.8–42.9)
44.4a
(35.3–53.5)

44.2a
(38.9–49.5)
37.8a
(32.8–42.8)

77.1
(67.0–87.1)
33.3
(26.7–39.8)
22.1
(16.8–27.4)
33.7
(27.6–40.9)

41.1a
(37.5–44.7)

167.1a
(165.2–169.0)

173.3a
(165.8–180.0)

IR = Incidence Rate, CI = Conﬁdence Interval, RR = Relative Risk.
a
Age-adjusted incidence rates.
* Signiﬁcant: p < .05.

Other

Race
NH-White

Female

Gender
Male

15–19

10–14

5–9

Age
0–4

All

NE
IR (95% CI)

SEER
IR (95% CI)

NE
IR (95% CI)

RR
RR (95% CI)

Leukemia

All Pediatric Cancers

43.0a
(41.9–44.2)
45.2a
(44.1–46.4)

44.7a
(43.4–46.1)
37.2a
(35.9–38.4)

76.2
(73.7–78.8)
37.0
(35.3–38.9)
26.7
(25.2–28.2)
25.9
(24.4–27.4)

41.0a
(40.1–42.0)

SEER
IR (95% CI)

0.9
(0.8–1.0)
1.0
(0.8–1.2)

1.0
(0.9–1.1)
1.0
(0.9–1.2)

1.0
(0.9–1.1)
0.9
(0.7–1.1)
0.8
(0.6–1.1)
1.3
(1.1–1.6)*

1.0
(0.9–1.1)

RR
RR (95% CI)

Table 2
Incidence rates of all and the three most common pediatric cancers in Nebraska and US/SEER (1990–2013) (rates per 1,000,000).

29.9a
(26.3–33.6)
17.2a
(11.8–22.6)

34.7a
(30.0–39.4)
21.0a
(17.3–24.7)

10.9
(7.1–14.7)
17.5
(12.7–22.2)
23.4
(17.9–28.8)
59.7
(51.4–69.0)

28.1a
(25.3–31.0)

NE
IR (95% CI)

Lymphoma

27.1a
(26.2–28.1)
20.1a
(19.3–20.9)

28.2a
(27.2–29.4)
20.7a
(19.8–21.7)

7.6
(6.8–8.4)
14.0
(12.9–15.1)
25.1
(23.7–26.6)
50.9
(48.8–53.1)

24.6a
(23.9–25.3)

SEER
IR (95% CI)

1.1
(1.0–1.3)
0.9
(0.6–1.1)

1.3
(1.1–1.4)*
1.0
(0.8–1.2)

1.4
(1.0–2.1)*
1.3
(0.9–1.7)
0.9
(0.7–1.2)
1.2
(1.0–1.4)*

1.1
(1.0–1.2)*

RR
RR (95% CI)

35.5a
(31.6–39.4)
22.6a
(16.2–29.1)

37.4a
(32.6–42.2)
29.1a
(24.7–33.5)

43.0
(35.5–50.5)
36.3
(29.4–43.1)
27.7
(21.7–33.6)
26.9
(21.5–33.4)

33.3a
(30.0–36.6)

NE
IR (95% CI)

CNS

34.2a
(33.1–35.3)
22.7a
(21.9–23.5)

32.5a
(31.4–33.7)
27.7a
(26.6–28.8)

40.2
(38.4–42.1)
32.8
(31.2–34.6)
27.3
(25.8 28.8)
20.7
(19.4–22.1)

30.2a
(29.4–31.0)

SEER
IR (95% CI)

1.0
(0.9–1.1)
1.0
(0.8–1.3)

1.2
(1.0–1.3)*
1.1
(0.9–1.2)

1.1
(0.9–1.3)
1.1
(0.9–1.3)
1.0
(0.8–1.2)
1.3
(1.0–1.6)*

1.1
(1.0–1.2)

RR
RR (95% CI)
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Fig. 1. Age-adjusted incidence rates of all pediatric cancers, leukemia, lymphoma, and brain and CNS tumors in Nebraska and SEER: 1990–2013. APC = Annual percentage change.

Furthermore, this age group presents a unique set of issues, including
fertility preservation, education, career development, employment, independence and decreased representation on clinical trials [38,39]. All
these issues are potentially magniﬁed in a rural area and should be
considered when developing an appropriate treatment plan. Consequently, these patients are increasingly vulnerable to the impacts of
access to care. Future studies can address issues regarding quality of life
and access to care related with education and future college attendance
for this age group in rural areas.
Finally, the spatial analyses based on LAA in GIS environment enabled us to address access to care issues concerning travel time. LAA
identiﬁed Kearney as the secondary location most suitable to minimize
the total travel time for Nebraska’s pediatric cancer patients. Using
Kearney and the two existing pediatric cancer locations in Omaha, we
estimated that over 90% of the pediatric cancer population is within 2 h
of these facilities (Fig. 3). This would improve ﬁnancial burden to rural
families, which was reported to be higher in a study addressing the
burden of pediatric cancer in patients and their families [32]. The pediatric cancer center in Kearney would cover patients from 20 of the 26
counties with higher pediatric cancer incidence compared to the state
average. Omaha would only serve 6 of those high incidence counties:
Burt, Dodge, and Butler (1–2 h driving distance), Platte (2–3 h driving
distance), and Knox and Antelope (3–4 h driving distance). This information could guide hospital systems and state legislators in the development of future care teams for pediatric cancer patients. Furthermore, this strategy can be utilized by other states to evaluate their own
populations and health care systems.
In summary, the incidence of pediatric cancer in Nebraska is similar
to the incidence in the United States over a 24-year period; however,
regional diﬀerences within Nebraska present a challenge for the health
management of rural populations. We believe that these challenges are
not unique to Nebraska, and other rural states may have similar issues.
Our investigations provide the framework for future studies, including
attempts to understand the interplay between environmental and genetic factors as potential explanations for the regional diﬀerences

Table 3
Incidence rates of CNS tumors in Nebraska and US/SEER: 1990–2003 and 2004–2013
(per 1,000,000).

All
Age
0–4
5–9
10–14
15–19
a

1990–2003

2004–2013

Malignant

Malignant

Benign and Uncertain

NE

SEER

NE

SEER

NE

SEER

29.8a

29.9a

38.1a

30.5a

22.7a

17.2a

37.2
29.0
29.0
24.2

39
32.1
28.4
20.6

50.3
46.4
25.7
30.6

41.9
33.8
25.8
20.9

16.2
24.0
24.9
25.2

9.7
10.4
16.3
32.0

Age-adjusted incidence rates.

lymphoma and CNS. The incidence rates for these cancers are higher in
Nebraska compared to US SEER for the latest years within that period.
It is interesting that for CNS tumors, both malignant and benign IRs are
higher in Nebraska and US SEER during 2004–2013. This may reﬂect an
increase in the etiologic factors for these tumor types, which include
radiation exposures. Interestingly, a nuclear plant is located in Nemaha
county which had the highest IRs of CNS tumors along with two other
surrounding counties (Pawnee and Richardson). Of note, Nebraska is
also a state with high levels of radon. There is a statewide program for
testing for the levels of radon in homes [36]. Notably, of the 24 counties
with higher levels of CNS tumors (labeled red on the map), 18 report
more than 50% of the homes having radon levels above 4.0 pCi/L [36].
Beyond these observations we cannot make any connections between
radiation exposures and increased incidence of CNS tumors in these
counties.
We also identiﬁed a statistically signiﬁcant increased RR in all
cancer types for patients aged 15–19. The NCI deﬁnes the adolescent
and young adult age group as beginning at 15 years of age. Previous
research shows that cancers of these patients are biologically and
clinically diﬀerent from those of their younger counterparts [37,38].
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Fig. 2. A. Pediatric Cancer Diagnoses in Nebraska, 1990–2013 (Incidence Rates* by County of Residence). B. Pediatric Brain Cancer Diagnoses in Nebraska, 1990–2013 (Incidence Rates*
by County of Residence) *Average annual number of new invasive cases per 1 million population < 20 years of age, age-adjusted to the 2000 US population.
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identiﬁed in Nebraska. In addition, survival studies comparing cancer
survival in urban vs rural populations is warranted.
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Fig. 3. Optimal Pediatric Cancer Treatment Facility Expansion Location (Minimum Impedance Analysis Method).
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